Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors. (Q51406538)

4 April 2018

title

Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors. (English)

1 reference

4 April 2018

author

Timothy Turner

4

1 reference

4 April 2018

Rosario Moratalla

5

1 reference

4 April 2018

David G. Standaert

6

1 reference

4 April 2018

author name string

Chen JF

1

1 reference

4 April 2018

Beilstein M

2

1 reference

4 April 2018

Xu YH

3

1 reference

4 April 2018

Aloyo VJ

7

1 reference

4 April 2018

Fink JS

8

1 reference

4 April 2018

Schwarzschild MA

9

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

4 April 2018

number of pages

10

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

4 April 2018

volume

97

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

195-204

1 reference

4 April 2018

Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

2-Phenylaminoadenosine stimulates dopamine synthesis in rat forebrain in vitro and in vivo via adenosine A2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Transgenic animals with inducible, targeted gene expression in brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine-dopamine interactions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Inducible gene expression in the nervous system of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Modulation of striatal dopaminergic function by local injection of 5'-N-ethylcarboxamide adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Behavioral and physiological effects of xanthines in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Addiction to cocaine and amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine receptor ligands: differences with acute versus chronic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a/D2 receptor interaction in globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Hard target: understanding dopaminergic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Molecular and cellular basis of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Locomotor activity in mice during chronic treatment with caffeine and withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Developments in the drug treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Differential responsiveness to cocaine in C57BL/6J and DBA/2J mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Ontogeny of gene expression of adenosine A2 receptor in the striatum: early localization in the patch compartment.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine A2 receptor-mediated excitatory actions on the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Multiple daily amphetamine administration: behavioral and neurochemical alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Molecular mechanisms of drug reinforcement and addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Using genetic mutations to study the neural basis of behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Prolonged time course of glutamate release from nerve terminals: relationship between stimulus duration and the secretory event.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

A2a adenosine receptor gene expression in developing rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Neurobiology of cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2900604-1

7 January 2021

10.1016/S0306-4522(99)00604-1

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

10771351

1 reference

4 April 2018